Hematopoietic growth factors: EPO, TPO and the CSFs
- Topic
Signal proteins tell the marrow how many of each blood cell to make. When one fails, as EPO does in kidney disease, the matching cell count falls.
What it is
Hematopoietic growth factors are glycoprotein cytokines that keep stem and progenitor cells alive, make them divide and push them toward a lineage. Some act on many lines (stem cell factor, IL-3, GM-CSF) and others on one (erythropoietin for red cells, G-CSF for neutrophils, M-CSF for monocytes, thrombopoietin for megakaryocytes, IL-5 for eosinophils, IL-7 for lymphocytes). Their production rises with need, which links the marrow to oxygen levels, infection and platelet mass.
Step by step
- Anaemia, lung disease or altitude lowers the oxygen reaching the kidney.
- Peritubular interstitial cells of the renal cortex sense the hypoxia (HIF is stabilised) and secrete erythropoietin.
- EPO acts on CFU-E and early erythroblasts, preventing their apoptosis and expanding their number.
- Reticulocytes rise in the blood within days.
- As oxygen delivery is restored, EPO falls again (negative feedback).
- In chronic kidney disease the sensor cells are lost, so EPO stays low and the anaemia persists.
Main factors and their targets
| Factor | Main source | Main target and effect |
|---|---|---|
| Erythropoietin (EPO) | Peritubular interstitial cells of the kidney (some liver) | Red cell progenitors (CFU-E); rises with hypoxia |
| Thrombopoietin (TPO) | Liver (constant production) | Megakaryocytes; level falls when platelet mass is high |
| G-CSF | Macrophages, endothelium, fibroblasts | Neutrophil production and release; mobilizes stem cells |
| GM-CSF | T cells, macrophages, endothelium | Granulocyte and monocyte progenitors |
| M-CSF | Macrophages, endothelium, fibroblasts | Monocytes, macrophages and osteoclasts |
| IL-3 and stem cell factor | T cells; marrow stroma | Early multipotent progenitors |
| IL-5 and IL-7 | T cells; marrow stroma | Eosinophils (IL-5); B and T lymphocyte precursors (IL-7) |
Clinical notes
- Chronic kidney disease lowers erythropoietin and causes a normocytic anaemia; recombinant erythropoiesis-stimulating agents treat it.
- Recombinant G-CSF shortens neutropenia after chemotherapy and mobilizes stem cells into blood for collection.
- Inappropriately high EPO (some renal and liver tumours, hypoxia at altitude) causes secondary polycythaemia; EPO is low in polycythaemia vera.
- Thrombopoietin-receptor agonists are used in some chronic immune thrombocytopenias.
Common traps
- Erythropoietin is made by renal tubular cells: it comes from peritubular interstitial cells of the renal cortex.
- The liver makes more thrombopoietin when platelets fall: it makes a steady amount; fewer platelets bind and clear it, so the free level rises.
- High erythropoietin points to polycythaemia vera: in polycythaemia vera EPO is low because the marrow is autonomous; high EPO means a secondary cause.
- G-CSF and GM-CSF do the same job: G-CSF acts on the neutrophil line; GM-CSF supports both granulocyte and monocyte progenitors.
Test yourself
Think of the answer, then tap the question to see it.
A patient with chronic kidney disease has a normocytic anaemia with few reticulocytes. Why?
The damaged kidney makes too little erythropoietin, so red cell progenitors are not stimulated despite the anaemia.
In thrombocytopenia from marrow failure the liver makes the same amount of thrombopoietin. Why is the free level high?
Platelets and megakaryocytes normally bind and remove thrombopoietin; when they are few, less is removed and more stays free.
How does erythropoietin help distinguish polycythaemia vera from secondary polycythaemia?
In polycythaemia vera the marrow is autonomous and EPO is low; in secondary polycythaemia EPO is normal or high.
Why is G-CSF given to a stem cell donor before collection?
Besides making neutrophils, it releases stem and progenitor cells from their marrow niches into the blood, where they can be collected.
Elsewhere in DurgiPedia
Connections
Educational content on normal microscopic structure and its clinical relevance; no substitute for studying slides or for a health professional's advice.
Sources: Erythropoietin test: MedlinePlus Medical Encyclopedia (MedlinePlus, US National Library of Medicine, 2025); Introduction to the Hematopoietic System | SEER Training (National Cancer Institute, SEER Training Modules, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
